Press Releases

Listed below are recent press releases. We only issue press releases for information that is relevant to our NHS customers. We do not Facebook, Instagram or Snapchat because we take what we do, supplying critical care medicines to the NHS, seriously. You cannot “follow us” or get “LinkedIn" to us (but you can call or email us and we will talk to you or call you back really quickly).
PDF Icon
Press Release - November 2021
Phebra acquires equity stake in UK specialty hospital pharma company Flexipharm Austrading
PDF Icon
Press Release - September 2020
Flexipharm Austrading announces protective vial sleeve to enhance user safety and performance of lead product, Arsenic Trioxide Phebra
PDF Icon
Press Release - March 2020
Flexipharm Austrading announces launch of first vial and first generic presentation of Methylthioninium Chloride
Improved presentation and lower price than alternative product for NHS hospitals
PDF Icon
Press Release - March 2020
Flexipharm Austrading announces product update on Arsenic Trioxide Phebra  
Extension to in-use stability time  
PDF Icon
Press Release - August 2019
Arsenic Trioxide Phebra included in the framework agreement for NHS National Pharmaceuticals Transition 2019_1. Offer reference number: CM/PHG/17/5547
PDF Icon
Press Release - May 2019
Flexipharm Austrading announces launch of Arsenic Trioxide Phebra (arsenic trioxide 1mg/ml concentrate for solution for infusion) 
Secure supply and first vial presentation of a pivotal drug for acute promyelocytic leukaemia


Listed below is a company overview. Please contact us if you need further information.
Power Point Icon
Company Overview

© Flexipharm Austrading Ltd 2022
Privacy Policy
Cookies Policy